Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Starup-Linde

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Endocrinology|March 14, 2013
Diabetes, biochemical markers of bone turnover, diabetes control, and boneJakob Starup-Linde
Bone|June 10, 2015
Response to: Bone alkaline phosphatase levels do not necessarily cause hypermineralization per seJakob Starup-Linde, Peter Vestergaard
Current Drug Safety|November 13, 2013
Diabetes, cancer and treatment - a mini-reviewPeter Vestergaard, Jakob Starup-Linde
Bone|February 28, 2015
Biochemical bone turnover markers in diabetes mellitus - A systematic reviewJakob Starup-Linde, Peter Vestergaard
European Journal of Endocrinology|August 6, 2015
Management of endocrine disease: Diabetes and osteoporosis: cause for concern?Jakob Starup-Linde, Peter Vestergaard
Bone|November 15, 2020
Does FRAX estimate fracture risk in patients with type 1 diabetes?Jakob Starup-Linde, Bente Langdahl, Torben Harsløf
Current Osteoporosis Reports|August 10, 2019
Osteoglycin and Bone-a Systematic ReviewJakob Starup-Linde, Rikke Viggers, Aase Handberg
Frontiers in Endocrinology|December 5, 2022
Editorial: Diabetes and bone - from cell to humanPeter Vestergaard, Antonino Catalano, Jakob Starup-Linde
Bone|March 25, 2023
Discrepancies in type of first major osteoporotic fracture and anti-osteoporotic therapy in elderly people with type 2 diabetes mellitus: A retrospective Danish cohort studyRikke Viggers, Jakob Starup-Linde, Peter Vestergaard
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
WITHDRAWN: Low-density lipoprotein cholesterol is associated with fracture risk in diabetes patients - a nested case-control studyJakob Starup-Linde, Soeren Gregersen, Peter Vestergaard
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Endocrinology|March 14, 2013
Diabetes, biochemical markers of bone turnover, diabetes control, and boneJakob Starup-Linde
Bone|June 10, 2015
Response to: Bone alkaline phosphatase levels do not necessarily cause hypermineralization per seJakob Starup-Linde, Peter Vestergaard
Current Drug Safety|November 13, 2013
Diabetes, cancer and treatment - a mini-reviewPeter Vestergaard, Jakob Starup-Linde
Bone|February 28, 2015
Biochemical bone turnover markers in diabetes mellitus - A systematic reviewJakob Starup-Linde, Peter Vestergaard
European Journal of Endocrinology|August 6, 2015
Management of endocrine disease: Diabetes and osteoporosis: cause for concern?Jakob Starup-Linde, Peter Vestergaard
Bone|November 15, 2020
Does FRAX estimate fracture risk in patients with type 1 diabetes?Jakob Starup-Linde, Bente Langdahl, Torben Harsløf
Current Osteoporosis Reports|August 10, 2019
Osteoglycin and Bone-a Systematic ReviewJakob Starup-Linde, Rikke Viggers, Aase Handberg
Frontiers in Endocrinology|December 5, 2022
Editorial: Diabetes and bone - from cell to humanPeter Vestergaard, Antonino Catalano, Jakob Starup-Linde
Bone|March 25, 2023
Discrepancies in type of first major osteoporotic fracture and anti-osteoporotic therapy in elderly people with type 2 diabetes mellitus: A retrospective Danish cohort studyRikke Viggers, Jakob Starup-Linde, Peter Vestergaard
The Journal of Clinical Endocrinology and Metabolism|January 18, 2014
WITHDRAWN: Low-density lipoprotein cholesterol is associated with fracture risk in diabetes patients - a nested case-control studyJakob Starup-Linde, Soeren Gregersen, Peter Vestergaard
Pageof 7